Michael serves as a primary research and analytical resource for Innovations and its partners with a focus on market assessment of new medical technologies. Prior to joining the Clinic, he spent more than 11 years at Health Research International, an independent medical market research and consulting firm, most recently as Vice President. This experience entailed working closely with a broad range of medical technology firms from local start-ups to multinationals. Michael earned a BA in business administration (cum laude, Marketing major) from the Richard T. Farmer School of Business at Miami University.
Susan Bernat is responsible for all fiduciary management including fiscal planning and other related financial activities. Susan also assists with establishing and implementing strategic goals and oversees long-range facilities planning. She also serves as the Director of Finance for the GCIC with responsibilities including development and implementation of strategy for ensuring financing of the GCIC consortium operations and management of financial performance and budgets. Prior to joining CCI, she was responsible for budget and contract negotiations within cardiology research at Cleveland Clinic. She received her undergraduate degree in Accounting from Kent State University, and an MBA from Cleveland State University.
Veronika’s function serves as liaison and administrative, technical, and operational resource for the Global Cardiovascular Innovation Center team. She has an extensive background providing support to senior-level Executives and world class service to all valued customers.
Phone: (216) 636-9952
Dr. Fortune serves as Senior General Manager, Cleveland Clinic Innovations. Prior to joining Cleveland Clinic, he was a Partner at Boston Millennia Partners, where he invested in early stage companies in pharmaceuticals and medical devices. Dr. Fortune has over 30 years of experience in the healthcare, life sciences and information technology sectors. He was previously President and Chief Operating Officer of New Era of Networks; Vice President at Monsanto; Vice President, at Bristol Myers Squibb;, Group President at Baxter International; and Vice President R&D at Baxter International. Dr. Fortune currently serves on the board of directors of Parexel International Corp, a global Contract
Research Organization as well as several private life sciences companies. He has been responsible for nurturing start-up activities from idea to prototype to standalone business. He has also been involved in some 30 M&A transactions from sourcing the company to closing the deal and successfully integrating the result. Pat has served on the engineering and scientific advisory boards of The University of Wisconsin, the University of Illinois, Cleveland Clinic, and the University of Chicago. Pat holds a BA from the University of Wisconsin, an MBA from Northwestern University, and a PhD in physical chemistry from the University of Wisconsin.
As a member of the Commercialization team, Kaleigh is the initial point of contact for Cleveland Clinic inventors who are considering the commercial potential of their inventions. In her current role, she advises inventors on the commercialization process and connects them with available resources. She works collaboratively with the Innovations team in the identification, marketing and commercialization of healthcare technologies. Kaleigh joins CCI with management experience in medical device sales. She received her BBA in Marketing, with a minor in Entrepreneurship, from the Richard T. Farmer School of Business at Miami University.
Grant's areas of focus within the licensing team are the Biomedical Engineering department and the Glickman Urological and Kidney Institute. He previously held positions within research and product development at Cook Medical, leading projects from idea conception through to commercialization. Grant holds a BS in Mechanical Engineering and an MS in Biomedical Engineering, both from Rose-Hulman Institute of Technology.
Phone: 216 444-0898
Mark Low comes to GCIC with a career of building successful programs to introduce new concepts and new modalities to new markets. He has managed all facets of product and market development spanning diagnostic and interventional cardiology, interventional radiology and neuroradiology, stroke treatment, image-guided surgery, drug delivery and oncology. He has served on the senior management team of TomTec Imaging Systems, Image Guided Technologies, EKOS Corporation, and Sonus Pharmaceuticals.
Prior to concentrating his focus on start-up ventures and early stage market development, Mr. Low held progressively more responsible and trailblazing positions in marketing and business development for Hewlett-Packard's Medical Products Group. Specializing in cardiovascular ultrasound, Mr. Low managed high performance cardiac diagnostic systems, introduced products to new market segments including private office and interventional cardiology, and developed new applications including 3D and stress echocardiography, and catheter-based intravascular ultrasound. In conjunction with these programs Mr. Low managed strategic relationships with various corporate partners, investors, universities, inventors, clinical investigators and manufacturers. Mr. Low received a B.A. degree in Natural Science from Johns Hopkins University, an M.S. degree in Physiology from the Medical College of Wisconsin, and an M.S. degree in Technical Communication from Rensselaer Polytechnic Institute.
Dr. Mayhugh's current focus is on technology commercialization in the ophthalmic therapeutic area. She joins CCI from Pfizer, Inc., where she was responsible for worldwide market analytics in age-related macular degeneration. Her previous experience also includes strategic consulting in the biotech, pharmaceutical, and medical device industries and research in neurodegenerative disease at the Massachusetts General Hospital. Dr. Mayhugh received her doctorate in Pharmacology and Toxicology at Dartmouth College and her undergraduate degree in Human Physiology at Boston University.
Matt McBride joined the Integrated Business Solutions team in 2012 after spending 12 years in the United States Navy. As a Naval Officer he served as Executive Officer of the Military Sealift Command in Diego Garcia, Program Manager for the V-22 Osprey in Philadelphia, and as the Contract Administrator for Forward Operating Base, Camp Leatherneck, in Afghanistan.
During his time as a military officer he had the opportunity to interact with leaders from a wide variety of industries and influence high-level business decisions often centering around engineering, contracts, and quality assurance. He is a graduate of the United States Naval Academy and is currently pursuing his M.B.A at Case Western Reserve University.
Sonja's current focus is commercializing innovations in healthcare information technology, primarily for the Cleveland Clinic and supporting HIT commercialization at its Alliance partners. Prior to joining CCI, Sonja was responsible for managing the life sciences client portfolio at Axentis, a Wolters Kluwer business, providing information, tools, and solutions to help health care professionals deliver quality results more efficiently.
Sonja has worked at the intersection of technology and health care throughout her career. Sonja's work has spanned clinical laboratory medicine as a MT (ASCP), consulting in the health care practice of Andersen Consulting, directing the process improvement practice within a health insurance organization, and building multiple startups as an early employee. Sonja is a certified PMP from the Project Management Institute and has a BS in Medical Technology from Miami University and an MBA from the Weatherhead School of Management at Case Western Reserve University.
Prior to joining CCI, Mr. O'Neill was Deputy Director of Battelle's Great Lakes Industrial Technology Center, where he facilitated licenses and other technology transfer partnerships with the NASA Glenn Research Center. Previously, he worked as a process engineer for a number of investment casting companies, supplying turbine blades to gas turbine engine manufacturers. Peter received a B.S. in aeronautical engineering from MIT. At CCI he is focusing on commercializing MEMS, orthopedic, and other medical device technologies.
Jason Ospina, PhD, Innovations Associate. Dr. Ospina is a member of our licensing team and primarily focuses on the evaluation, marketing and commercialization of life science disclosures. Prior to joining CCI, Jason was a post-doctoral fellow at Cleveland Clinic's Lerner Research Institute. His research at Lerner centered on the delineation of mechanisms regulating Hedgehog signal transduction and the influence of protein phosphorylation on pathway outcomes. Jason received his Ph.D. in Genetics from Case Western Reserve University, where his thesis work examined nuclear protein dynamics and transport, as well as ribonucleoprotein biogenesis.
As a member of the licensing team, Marcie's primary focus is on the evaluation, marketing and commercialization of disclosures related to medical device technologies. Prior to joining CCI, Marcie held several product development positions at Kensey Nash Corporation in the fields of interventional cardiology and soft tissue repair, culminating in the role of Senior Biomaterials Engineer. Marcie has B.S. and M.S. degrees in Materials Engineering, both from Drexel University in Philadelphia.
Charles Steiner, Manager, Director, Product Development, started with Cleveland Clinic in the late 1980's developing surgical navigation systems for the fields of neurological and spine surgery. He holds several patents for frameless stereotactic surgery and medical data communication. As director of product development for the Minimally Invasive Surgery Center he developed a multidisciplinary surgical teaching facility replete with surgical simulators, tele-robotic systems and medical informatics resources. As manager for the BNMC he directs a multispeciality team of neurosurgeons, neurologists, neuroscientists, biomedical engineers and commercial partners to develop next generation neuromodulation technologies. Charles earned degrees in Chemistry and Computer Science from Case Western Reserve University.
Dr. Stovsky serves as Science and Technology Innovation Officer at Cleveland Clinic Innovations. In addition to his work at Innovations, Dr. Stovsky, a board certified urologist, is an Associate Professor of Surgery and a Staff Urologist in the Glickman Urological and Kidney Institute where he specializes in the managment of benign and malignant prostate disease, minimally invasive surgery for BPH, advanced endourology for urinary stone disease, men's health, medical economics and bioinformatics. His research interests include cancer biomarkers, urinary stone disease, BPH and medical economics/health policy.
Prior to joining CCF and CCF Innovations, Dr. Stovsky was an attending urologist at University Hospitals Case Medical Center where he served as Director of the Men's Health and Genitourinary Stone Center and Urology Institute Quality Officer as well as Chief of the Division of Urology and Medical Director for Urology Services at UH Richmond Medical Center.
Dr. Stovsky has an extensive business background in both private equity and life science consulting as well as new venture development. Dr. Stovsky currently serves on the boards of the American Association of Clinical Urologists, the American Urological Association (AUA) North Central Section and the Ohio Urological Society. He is Past President of the Cleveland Urological Society and the Ohio Urological Society as well as a past board member of the Acedemy of Medicine of Cleveland/Northern Ohio Medical Association. Dr. Stovsky was recently selected to the AUA Leadership Program (2012/2013 class). He has also been honored with selection to Best Doctors in America (2010 - 2013). He also serves on the boards of American Friends of Magen David Adom (Israel Red Cross) and Park Synagogue.
Dr. Stovsky earned undergraduate and medical degrees from Northwestern. He also holds an MBA (strategic planning) from the Katz Graduate School of Business at the University of Pittsburgh where he was elected to Beta Gamma Sigma. Dr. Stovsky completed his urology residency training at University Hospitals Case Medical Center in Cleveland, Ohio.
Dr. Stovsky is married to Shannon and they have 3 children, Adam, Jennifer and Jacob.
Phone: 216-621-2234 ext. 110
Jim Zalar is the Assistant Director for Integrated Business Strategies. Prior to joining IBS group, he was Institute Administrator for the Orthopaedic and Rheumatologic Institute. He was responsible for day to day management of the orthopaedic, rheumatology, outpatient physical therapy and orthotic and prosthetics product lines. Prior to being Institute Administrator, Jim worked at PriceWaterhouseCoopers and Ernst and Young as a Healthcare Consultant. Jim is a graduate of John Carroll University and has an MBA. His primary focus is emerging business opportunities.
Innovations has facilitated several Cleveland Clinic Spin-Offs over the last decade. Click here to see our current portfolio.
The Alliance network strives to realize new opportunities for innovation by gaining a 360-degree perspective on healthcare and its future.
Cleveland Clinic © 2014